2020-10-22T16:36:31-07:00 2020-06-30 352317502 Bunker & Company LLP 4340 Redwood Hwy Suite 117 San Rafael CA 94903 990 2019-07-01 942495035 GLAUCOMA RESEARCH FOUNDATION GLAU 4159863162 251 POST STREET STE 600 SAN FRANCISCO CA 94108 THOMAS M BRUNNER President & CEO 2020-10-22 true Joseph C Bunker P00204452 4154997661 2019 2021-01-29 14:40:06Z THOMAS M BRUNNER 251 POST STREET STE 600 SAN FRANCISCO CA 94108 6093365 false X www.glaucoma.org X 1978 CA Cure Glaucoma and restore vision through innovative research. 13 12 9 25 0 1872259 4199098 602319 472915 586444 649103 318907 508075 3379929 5829191 1395428 1586618 0 1312582 1448186 0 542479 1363695 1271910 4071705 4306714 -691776 1522477 10976910 12305821 728352 1118274 10248558 11187547 Cure Glaucoma and restore vision through innovative research. false false 3584026 THE ORGANIZATION PROMOTES AND SUPPORTS RESEARCH AND EDUCATION CONCERNING THE CAUSES AND TREATMENT OF GLAUCOMA. IT HAS BEEN A LEADER IN COLLABORATIVE RESEARCH THROUGH THE LANDMARK MULTI-CENTER NORMAL TENSION GLAUCOMA STUDY WHICH TRANSFORMED GLAUCOMA TREATMENT, AS WELL AS THE CREATION OF THE "CATALYST FOR A CURE" (CFC). THIS UNIQUE RESEARCH MODEL BRINGS TOGETHER SCIENTISTS FROM DIFFERENT DISCIPLINES TO WORK TOGETHER TO UNDERSTAND GLAUCOMA AND FIND WAYS TO IMPROVE TREATMENT AND FIND A CURE. THE FIRST CFC TEAM MADE A SIGNIFICANT IMPACT ON THE FIELD OF GLAUCOMA AND HELPED TO TRANSFORM THE UNDERSTANDING OF GLAUCOMA FROM AN EYE DISEASE TO A NEURODEGENERATIVE DISEASE.TAKING THE FINDINGS FROM THE FIRST TEAM, A SECOND CFC TEAM WAS CREATED TO DEVELOP NEW BIOMARKERS TO DIAGNOSE AND MANAGE GLAUCOMA MORE EFFECTIVELY BEFORE VISION IS LOST AND OPEN PATHWAYS TO NEW TREATMENT OPTIONS FOR PATIENTS. A third CFC Team was launched in January to discover ways to restore vision lost to glaucoma by restoring, regenerating or replacing the retinal ganglion cells damaged in glaucoma.THE ORGANIZATION ALSO PROVIDES FUNDING FOR INNOVATIVE PILOT STUDIES IN GLAUCOMA RESEARCH. THESE INCUBATOR GRANTS ENABLE SCIENTISTS TO INVESTIGATE A NOVEL AND PROMISING IDEA AND GATHER CRITICAL DATA TO CONTINUE THEIR RESEARCH AND SECURE ADDITIONAL FUNDING. THIS PROGRAM CONTINUES TO NURTURE THE CAREERS OF PROMISING GLAUCOMA INVESTIGATORS AND BRING NEW IDEAS TO THE FIELD OF GLAUCOMA RESEARCH. IN ADDITION, THE ORGANIZATION SERVES AS A PRIMARY SOURCE OF INFORMATION AND SUPPORT FOR PATIENTS BY PROVIDING UNBIASED EDUCATIONAL MATERIALS IN PRINT AND ONLINE. 3584026 true true false false false false false false false true true false false true true false true false false false false false false false true false false true false true false false false false false false false false true false false false false false false false false true 18 0 true 9 true false false false false false true true false 0 false false false false false false false X 13 12 false false false false false false false true true false false true true true true true true true true false CA X X X GLAUCOMA RESEARCH FOUNDATION 4159863162 251 POST ST 600 SAN FRANCISCO CA 94108 THOMAS M BRUNNER President & CEO 32.00 0.00 X X 210468 0 10523 NANCY GRAYDON E.D. DEVEL. & COO 40.00 0.00 206197 0 10310 ANDREW JACKSON DIR. COMMUNICATION 40.00 0.00 129845 0 6492 CATALINA SAN AGUSTIN DIRECTOR OPERATION 40.00 0.00 127502 0 5529 Meredith Gale Dir. Development 40.00 0.00 119045 0 5952 ANDREW G IWACH MD CHAIR 2.00 0.00 X X 0 0 0 RUTH D WILLIAMS MD VICE CHAIR 2.00 0.00 X X 0 0 0 CHARLES R WILMOTH Treasurer 2.00 0.00 X X 0 0 0 RICK HALPRIN CPA Secretary 2.00 0.00 X X 0 0 0 FREDERICK H BRINKMANN Director 2.00 0.00 X 0 0 0 Nancy S Forster Director 2.00 0.00 X 0 0 0 MONICA L VETTER PHD Director 2.00 0.00 X 0 0 0 ROBERT L STAMPER MD Director 2.00 0.00 X 0 0 0 DENNIS E SINGLETON Director 2.00 0.00 X 0 0 0 LINDA C LINCK Director 2.00 0.00 X 0 0 0 ADRIENNE L GRAVES PHD Director 2.00 0.00 X 0 0 0 John G Flanagan PHD Director 2.00 0.00 X 0 0 0 793057 38806 5 false true false Jacqueline Jones Design 346 G St San Rafael CA 94901 Graphic Design & Printing 302544 1 4199098 117754 4199098 CONFERENCE/FORUM 472915 472915 472915 555299 555299 0 0 0 93804 93804 93804 93804 759550 264174 495376 495376 0 0 MISCELLANEOUS 12699 12699 12699 5829191 485614 1144479 1586618 1586618 0 0 0 220991 187842 16574 16575 0 1227195 873335 108654 245206 0 0 0 0 0 0 0 0 0 0 0 0 0 0 161400 118232 14031 29137 0 0 0 0 0 0 0 OPERATING EXPENSES 516967 349903 14710 152354 OTHER EXPENSES 362927 348018 14909 CONSULTING EXPENSES 230616 120078 26240 84298 0 4306714 3584026 180209 542479 219220 1045012 419508 2470223 846264 1713560 0 0 0 0 34265 28918 134475 134034 104647 75580 41295 29067 5770989 3384123 0 0 0 3510894 3500884 10976910 12305821 147102 150844 581250 800000 167430 728352 1118274 X 4007922 3901128 6240636 7286419 10248558 11187547 10976910 12305821 X 1522477 -585074 1586 X false true X true false X 3121339 3230442 3729663 1872259 4199098 16152801 0 0 3121339 3230442 3729663 1872259 4199098 16152801 2443052 13709749 375116 262504 403695 586635 555299 2183249 0 221361 404449 423010 318907 508075 1875802 20211852 2260640 0.67830 0.64320 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 3342500 3342500 3342500 3342500 3342500 3342500 3342500 3342500 3342500 3342500 1.00000 false false false 3363 3363 101284 72217 29067 29067 ASSETS HELD IN TRUST - MUTUAL FUNDS 158384 PERMANENTLY RESTRICTED INVESTMENTS 3342500 3500884 CARES ACT U.S. GOVT 167430 167430 5509877 -585074 265760 -319314 5829191 5829191 4570888 264174 264174 4306714 4306714 Part V, Line 4: Intended uses of the endowment fund. Permanently restricted funds are allocated as: Annual Research Grant, $800,000;Research and Annual Sutro Lecture, $2,542,000.THE ANNUAL INCOME FROM "THE DR. HENRY A. SUTRO FAMILY GRANT FOR RESEARCH" WILL BE USED FOR SPECIAL INVESTIGATIONS.THE ANNUAL INCOME FROM $1,000,000 OF THE ENDOWMENT WILL BE USED FOR THE "DRS. HENRY AND FREDERICK SUTRO MEMORIAL LECTURE" Part XI, Line 2d: Other revenue amounts included in F/S but not included on form 990 Event expenses $264174 Change in value of charitable trust $1586 Part XII, Line 2d: Other expenses and losses per audited F/S Event expenses $264174 false EVENTS 759550 759550 264174 759550 759550 264174 264174 495376 true A Einstein College Medicine 1300 Morris Park Ave Bronx NY 10461 830621846 50000 0 GLAUCOMA RESEARCH Baylor College One Baylor Plaza Houston TX 77030 741613878 50000 0 GLAUCOMA RESEARCH Doheny Eye Institute PO Box 86228 Los Angeles CA 90086 952916590 50000 0 GLAUCOMA RESEARCH GLAUCOMA REASERCH & EDUCATION 55 STEVENSON ST SAN FRANCISCO CA 94105 943208182 456250 0 GLAUCOMA RESEARCH MEDICAL COLLEGE OF WISCONSIN 8701 Watertown Plank Rd MILWAUKEE WI 53226 390806261 50000 0 GLAUCOMA RESEARCH RESEARCH TO PREVENT BLINDNESS 360 LEXINGTON AVE FL 22 NEW YORK NY 10017 131945117 15000 0 GLAUCOMA RESEARCH SCHEPENS EYE RESEARCH INST PO Box 412360 BOSTON MA 02241 042129889 50000 0 GLAUCOMA RESEARCH STANFORD UNIVERSITY PO Box 44253 San Francisco CA 94144 941156365 200000 0 GLAUCOMA RESEARCH State University of New York 33 W 42nd St New York NY 10036 146013200 50000 0 GLAUCOMA RESEARCH UC DAVIS PO Box 989062 West Sacramento CA 95798 946036494 200000 0 GLAUCOMA RESEARCH UC SAN DIEGO 9500 GILMAN DR MC 0009 LA JOLLA CA 92093 952872494 200000 0 GLAUCOMA RESEARCH UC SAN FRANCISCO PO Box 748872 Los Angeles CA 90074 946036493 200000 0 GLAUCOMA RESEARCH UPMC Eye Center 203 Lothrop St Pittsburgh PA 15219 251423657 7500 0 GLAUCOMA RESEARCH VANDERBUILT EYE INSTITUTE 2311 Pierce Ave NASHVILLE TN 37232 352528741 50000 0 GLAUCOMA RESEARCH WASHINGTON UNIVERSITY 700 Rosedale Ave ST LOUIS MO 63112 430653611 50000 0 GLAUCOMA RESEARCH 15 0 X X X X X false false false false false false false false false NANCY GRAYDON E.D. DEVEL. & COO 206197 10310 216507 THOMAS M BRUNNER President & CEO 210468 10523 220991 X 14 117754 FMV false false false Form 990, Part VI, Line 11b: Form 990 Review Process STAFF REVIEW, COPY EMAILED TO BOARD FOR REVIEW/COMMENTS Form 990, Part VI, Line 12c: Explanation of Monitoring and Enforcement of Conflicts COMPLIANCE FORMS SENT EVERY JULY Form 990, Part VI, Line 15a: Compensation Review & Approval Process - CEO, Top Management Performance review by Board & Compensation Committee. Compensation Committee uses Salary Surveys and approves CEO compensation at Boards direction. Form 990, Part VI, Line 15b: Compensation Review and Approval Process for Officers and Key Employees Annual review by supervisor and approval by next level manager with use of comparability data Form 990, Part VI, Line 19: Other Organization Documents Publicly Available UPON REQUEST Other Changes In Net Assets Or Fund Balances - Other Increases CHANGE IN VALUE CHARITABLE TRUST = $1586